Marc Alexander Radtke1, Ulrich Mrowietz2, Julia Feuerhahn1, Martin Härter3, Ralph von Kiedrowski4, Alexander Nast5, Kristian Reich6, Klaus Strömer7, Johannes Wohlrab8, Matthias Augustin1. 1. Institute for Health Services Research in Dermatology and Nursing (IVPD), German Center for Health Sevices Research in Dermatology (CVderm), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 2. Center for Psoriasis, Department of Dermatology, Venereology, and Allergology, University Hospital Schleswig- Holstein, Campus Kiel, Kiel, Germany. 3. Institute and Outpatient Clinic for Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 4. Dermatological Practice, Selters, Germany. 5. Division of Evidence-based Medicine (dEBM), Department of Dermatology, Venereology, and Allergology at the Charité - Medical Faculty of the University of Berlin, Berlin, Germany. 6. Dermatologikum Hamburg, Hamburg, Germany. 7. Dermatological Practice Mönchengladbach, Mönchengladbach, Germany. 8. Department of Dermatology and Venereology, University Hospital Halle, Halle, Germany.
Abstract
BACKGROUND: Psoriasis is associated with an increased rate of comorbidities, whose early detection has been adopted into the national healthcare goals. To date, agreed recommendations on early detection in the context of routine dermatological care are missing. The objective of this study was the interdisciplinary development of screening algorithms. METHODS: The development of the consensus paper was based on a three-step process. First, the National Conference on Healthcare in Psoriasis, convening on behalf of the German Society of Dermatology (DDG) and the Professional Association of German Dermatologists (BVDD), developed a definition of the requirements, areas of application, conception, and methodology of a screening tool. Secondly, based on a literature search, individual working groups compiled evidence for the use of screening parameters. In a third step, an interdisciplinary working group adopted the algorithms in a Delphi consensus process. RESULTS: The associated working groups evaluated more than 2,000 publications on 15 different comorbidities. A screening algorithm was agreed on for the following twelve indications: arterial hypertension, dyslipidemia, obesity, diabetes mellitus, metabolic syndrome, nonalcoholic steatohepatitis, depression, nicotine abuse, alcohol abuse, chronic inflammatory bowel disease, psoriasis arthritis, and malignant lymphoma. In this context, the requirements of everyday dermatological care were addressed in particular. CONCLUSIONS: With respect to screening for comorbidities in psoriasis, standardized and consented algorithms are available, which - on national level - may be implemented as a screening tool within the framework of PsoNet - German Psoriasis Networks.
BACKGROUND:Psoriasis is associated with an increased rate of comorbidities, whose early detection has been adopted into the national healthcare goals. To date, agreed recommendations on early detection in the context of routine dermatological care are missing. The objective of this study was the interdisciplinary development of screening algorithms. METHODS: The development of the consensus paper was based on a three-step process. First, the National Conference on Healthcare in Psoriasis, convening on behalf of the German Society of Dermatology (DDG) and the Professional Association of German Dermatologists (BVDD), developed a definition of the requirements, areas of application, conception, and methodology of a screening tool. Secondly, based on a literature search, individual working groups compiled evidence for the use of screening parameters. In a third step, an interdisciplinary working group adopted the algorithms in a Delphi consensus process. RESULTS: The associated working groups evaluated more than 2,000 publications on 15 different comorbidities. A screening algorithm was agreed on for the following twelve indications: arterial hypertension, dyslipidemia, obesity, diabetes mellitus, metabolic syndrome, nonalcoholic steatohepatitis, depression, nicotine abuse, alcohol abuse, chronic inflammatory bowel disease, psoriasis arthritis, and malignant lymphoma. In this context, the requirements of everyday dermatological care were addressed in particular. CONCLUSIONS: With respect to screening for comorbidities in psoriasis, standardized and consented algorithms are available, which - on national level - may be implemented as a screening tool within the framework of PsoNet - German Psoriasis Networks.
Authors: Emily Osier; Audrey S Wang; Megha M Tollefson; Kelly M Cordoro; Stephen R Daniels; Andrew Eichenfield; Joel M Gelfand; Alice B Gottlieb; Alexa B Kimball; Mark Lebwohl; Nehal N Mehta; Amy S Paller; Jeffrey B Schwimmer; Dennis M Styne; Abby S Van Voorhees; Wynnis L Tom; Lawrence F Eichenfield Journal: JAMA Dermatol Date: 2017-07-01 Impact factor: 10.282
Authors: M Augustin; L Eissing; A Langenbruch; A Enk; T Luger; D Maaßen; U Mrowietz; K Reich; M Reusch; K Strömer; D Thaçi; R von Kiedrowski; M A Radtke Journal: Arch Dermatol Res Date: 2016-04-05 Impact factor: 3.017
Authors: Melita Vuksic Polic; Maja Miskulin; Martina Smolic; Kristina Kralik; Ivan Miskulin; Maja Cigrovski Berkovic; Ines Bilic Curcic Journal: Int J Environ Res Public Health Date: 2018-07-13 Impact factor: 3.390